Novo Nordisk is discontinuing all Levemir products, and the current expectation is that remaining supplies will be exhausted by the end of December 2026. NHS guidance is that patients should be reviewed and switched to an alternative basal insulin well before supplies run out.
Hints & Tips Correct At Time of Going to Press
Please check the publish date of the article, to ensure you are using the most up-to-date information
Free Monthly Hints & Tips
![]()
Our monthly newsletter is packed with helpful hints and tips to help you boost practice productivity, grow your revenue and make the best of your existing technology.
